Teva Pharmaceutical Industries Ltd (TEVA) operating KPIs
TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 7/30122% above fair value
$41.47+1.50 (+3.75%)
Close on Oct 29, 2026Market cap $48.32BP/E 69.1Yield –
KPIs
Operating metrics that drive Teva Pharmaceutical Industries's business
Coming soon
This tab will track the numbers specific to Teva Pharmaceutical Industries's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.